Haleos Labs Limited (NSE:HALEOSLABS)
1,438.20
+15.10 (1.06%)
Jun 16, 2026, 9:30 AM IST
Haleos Labs Revenue
In the fiscal year ending March 31, 2026, Haleos Labs had annual revenue of 3.34B INR, down -3.17%. Haleos Labs had revenue of 751.39M in the quarter ending March 31, 2026, a decrease of -15.68%.
Revenue
3.34B
Revenue Growth
-3.17%
P/S Ratio
1.29
Revenue / Employee
5.64M
Employees
592
Market Cap
4.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.34B | -109.29M | -3.17% |
| Mar 31, 2025 | 3.45B | 387.65M | 12.67% |
| Mar 31, 2024 | 3.06B | -96.02M | -3.04% |
| Mar 31, 2023 | 3.16B | -345.11M | -9.86% |
| Mar 31, 2022 | 3.50B | 844.79M | 31.81% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biocon | 169.27B |
| Dishman Carbogen Amcis | 29.32B |
| Anthem Biosciences | 21.24B |
| OneSource Specialty Pharma | 14.22B |
| Concord Biotech | 10.55B |
| Blue Jet Healthcare | 9.47B |
| Supriya Lifescience | 8.28B |
| Panacea Biotec | 6.40B |